Synopsis Amiodarone, originally developed over 20 years ago, is a potent antiarrhythmic
drug with the actions of all antiarrhythmic drug classes. It has been successfully used in the …

Objectives We sought to develop an explicit evidence‐based model of medication
monitoring and to evaluate monitoring practices and adverse drug events in patients taking …

A comparative study of the plasma disposition and tissue distribution of amiodarone and its
proximate metabolite, desethylamiodarone, for a single oral dose and short-term oral …

Pharmacokinetic-dynamic relations for amiodarone have been difficult to define. Few studies
have successfully correlated serum amiodarone concentration with either dose or …

Lo" lO\lC'lhcrapcutlc doSt'ratIO.:!. l'nC\IX'clcd\arlllblllt~ In pharmacokmellcs. 3. ThcralX'ulic
end-point nOI casll~ measured (('. g proph~ 13\, 5 of St'rlOUS and rarc c, cnIS).-\nllarrh) …

We report the successful management of recurrent ventricular tachycardias in a newborn
suffering from an intracardiac tumor. Amiodarone was the only agent able to control the …

Publisher Summary This chapter explores the side effects of positive inotropic drugs and
drugs used in dysrhythmias. In the positive inotropic drugs, the chapter focuses on cardiac …

Per monitoraggio dei farmaci, o TDM, si intende la misurazione della concentrazione di
farmaci nei liquidi biologici per aiutare la gestione dei pazienti che assumono farmaci per la …

Propósito y Método del Estudio: El propósito de este estudio fue determinar amiodarona y
desetilamiodarona en plasma y eritrocitos de pacientes con terapia crónica antiarrítmica y …